News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR awarded £30 million towards new Centre for Cancer Drug Discovery
The Institute of Cancer Research has secured a £30 million grant from the Higher Education Funding Council for England (HEFCE) towards the costs of building a new, state-of-the-art drug discovery facility.
ICR Awards Ceremony celebrates graduating students and pioneering researchers
Three internationally recognised cancer researchers have been honoured alongside graduating students and former staff members at the annual ICR Awards Ceremony.
First ever Teaching Week to promote the ICR’s academic excellence
The ICR will be underlining its credentials as a global leader in cancer research, education and training through a series of communication activities during its first ever Teaching Week.
Time since chemotherapy may predict response to olaparib in ovarian cancer
Women with advanced ovarian cancer who begin treatment with olaparib are more likely to respond to the drug if it has been more than a year since their last round of chemotherapy, according to new research.
Immunotherapy kinder than chemotherapy for patients with head and neck cancer
The immunotherapy nivolumab is kinder than chemotherapy for people with advanced head and neck cancer – easing many of the negative effects of the disease on patients’ quality of life.
ICR scientist Dr Sebastian Guettler awarded prestigious Lister Prize
Dr Sebastian Guettler, a Team Leader at The Institute of Cancer Research, London, has been recognised as one of the most promising young biomedical researchers in the UK and awarded a Lister Institute Research Prize Fellowship.
Seven new DNA regions linked to kidney cancer risk
Researchers have found seven new single-letter changes to DNA that are linked to an increased chance of developing renal cell carcinoma.
New three-in-one blood test opens door to precision medicine for prostate cancer
Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes.
Better treatment for high-risk children’s cancer shown in major trial
Children with a high-risk, deadly form of neuroblastoma will benefit from a treatment regime that improves survival and reduces side-effects, following the publication of a major European trial.
Genetic testing can pick out men at increased risk of testicular cancer
Testing for large numbers of genetic changes can identify men with over a 10-fold increased risk of testicular cancer, a new study shows.
New chemotherapy approach offers breast cancer patients a better quality of life
Using a different chemotherapy drug to prevent the return of breast cancer is just as effective as the current standard approach and crucially means a better quality of life, according to a new clinical trial.
ASCO 2017: Adding abiraterone to standard treatment improves prostate cancer survival by almost 40%
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37%, according to the results of one of the largest-ever clinical trials for prostate cancer.
